RVL Pharmaceuticals
Nicole Domanski-Rudnik is a marketing professional with experience in various roles within the marketing field. Currently serving as a Marketing Associate at RVL Pharmaceuticals since January 2023, Nicole previously worked as a Marketing Coordinator at Laurel Circle from May 2021 to January 2023. Nicole's background also includes a position as Supervisor at the Ithaca College Annual Fund from October 2016 to May 2019 and an internship as a Social Media Intern at Embrace Relief during the summer of 2018, where responsibilities included managing social media accounts and creating content across multiple platforms. Nicole holds a Bachelor's degree in Integrated Marketing Communication from Ithaca College, earned in 2019.
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.